HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV type 1 seronegative Ugandans

被引:24
作者
Kebba, A
Kaleebu, P
Serwanga, J
Rowland, S
Yirrell, D
Downing, R
Gilmour, J
Imami, N
Gotch, F
Whitworth, J
机构
[1] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London SW10 9NH, England
[2] UVRI, Med Res Councils Programme AIDS Uganda, Entebbe, Uganda
[3] Univ Edinburgh, Ctr HIV Res, Edinburgh EH9 3JN, Midlothian, Scotland
[4] Ctr Dis Control & Prevent, Entebbe, Uganda
关键词
D O I
10.1089/088922204322749512
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+) T cell help is important for the functionality of CD8(+) cytotoxic T-lymphocytes (CTLs) in limiting viral replication and may contribute to mediation of apparent resistance to HIV-1 infection in exposed seronegative (ESN) individuals. Using five HIV-1 antigens in an intracellular cytokine assay, the presence of specific antigen-responsive interferon-gamma-positive (IFN-gamma(+)) CD69(+) CD4(+) T-lymphocytes was evaluated in ESNs, their seropositive partners, and unexposed seronegative controls. Ten ESNs ( five females, five uncircumcised males) were identified from 10 HIV-1 serodiscordant couples with a history of frequent unprotected sexual intercourse. All ESNs and controls were negative on two EIAs and for HIV-1 proviral DNA. The frequency of ESNs with antigen-responsive IFN-gamma(+) CD69(+) CD4(+) T-lymphocytes ranged from three to five of eight for the different HIV-1 antigens. Six of eight ESNs tested had a positive response to at least one of the five antigens. Responses were on average 3.5 times higher among seropositives compared to ESNs and absent in the five unexposed controls. A negative correlation was noted between responses in ESNs and the plasma viral load of their seropositive spouse. Clade-specific and cross-clade reactivity were noted in both ESNs and seropositive partners tested. The findings confirm that ESNs are in a state of HIV-1-specific immune activation and suggest that HIV-1-specific IFN-gamma(+) CD69(+) CD4(+) T-lymphocytes in addition to HIV-1-specific CD8(+) CTLs already described by others are potential immunological correlates of protection from persistent HIV-1 infection.
引用
收藏
页码:67 / 75
页数:9
相关论文
共 41 条
[1]   Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons [J].
Bernard, NF ;
Yannakis, CM ;
Lee, JS ;
Tsoukas, CM .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03) :538-547
[2]   Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type I highly exposed, persistently seronegative female sex workers in northern Thailand [J].
Beyrer, C ;
Artenstein, AW ;
Rugpao, S ;
Stephens, H ;
VanCott, TC ;
Robb, ML ;
Rinkaew, M ;
Birx, DL ;
Khamboonruang, C ;
Zimmerman, PA ;
Nelson, KE ;
Natpratan, C .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01) :59-67
[3]   Factors contributing to the lack of human immunodeficiency virus type 1 (HIV-1) transmission in HIV-1-discordant partners [J].
Bienzle, D ;
MacDonald, KS ;
Smaill, FM ;
Kovacs, C ;
Baqi, M ;
Courssaris, B ;
Luscher, MA ;
Walmsley, SL ;
Rosenthal, KL .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (01) :123-132
[4]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[5]   BIOLOGY OF CLONED CYTO-TOXIC LYMPHOCYTES-T SPECIFIC FOR LYMPHOCYTIC CHORIOMENINGITIS VIRUS - CLEARANCE OF VIRUS INVIVO [J].
BYRNE, JA ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1984, 51 (03) :682-686
[6]   HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant [J].
Choi, DJ ;
Dube, S ;
Spicer, TP ;
Slade, HB ;
Jensen, FC ;
Poiesz, BJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (04) :357-361
[7]   A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected Thai subjects with CD4-Cell counts of >300 [J].
Churdboonchart, V ;
Sakondhavat, C ;
Kulpradist, S ;
Isarangkura, B ;
Ayudthya, BIN ;
Chandeying, V ;
Rugpao, S ;
Boonshuyar, C ;
Sukeepaisarncharoen, W ;
Sirawaraporn, W ;
Carlo, DJ ;
Moss, R .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (05) :728-733
[8]   HIV-1-specific cellular immune responses among HIV-1-resistant sex workers [J].
Fowke, KR ;
Kaul, R ;
Rosenthal, KL ;
Oyugi, J ;
Kimani, J ;
Rutherford, WJ ;
Nagelkerke, NJD ;
Ball, TB ;
Bwayo, JJ ;
Simonsen, JN ;
Shearer, GM ;
Plummer, FA .
IMMUNOLOGY AND CELL BIOLOGY, 2000, 78 (06) :586-595
[9]   Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: Evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects [J].
Goh, WC ;
Markee, J ;
Akridge, RE ;
Meldorf, M ;
Musey, L ;
Karchmer, T ;
Krone, M ;
Collier, A ;
Corey, L ;
Emerman, M ;
McElrath, MJ .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03) :548-557
[10]   Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract [J].
Hart, CE ;
Lennox, JL ;
Pratt-Palmore, M ;
Wright, TC ;
Schinazi, RF ;
Evans-Strickfaden, T ;
Bush, TJ ;
Schnell, C ;
Conley, LJ ;
Clancy, KA ;
Ellerbrock, TV .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (04) :871-882